Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pain 3Fatigue 3Breast Neoplasms 3Anxiety Disorders 3Vomiting 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Nausea 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Agnosia 1

Interventions

Psychiatric Rehabilitation 3Early Intervention, Educational 3Carboplatin 3Behavior Therapy 3Surgical Procedures, Operative 2Specimen Handling 2Platinum 2Palliative Care 2Methods 2Hyperthermic Intraperitoneal Chemotherapy 2Gene Expression Profiling 2Cisplatin 2Blood Specimen Collection 2taxane 1oregovomab 1motexafin lutetium 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Touch 1Taxes 1Standard of Care 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Sodium Chloride 1Serotonin Plasma Membrane Transport Proteins 1Radiotherapy 1Propranolol 1Preoperative Exercise 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Fallopian Tube Neoplasms × Touch × Clear all
NCT00293293 2017-12-28

Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine

Masonic Cancer Center, University of Minnesota

Phase NA Completed
43 enrolled 22 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡